Chugai Pharmaceutical Co., Ltd. (4519)

3,985.0
-19.0(-0.47%)
  • Volume:
    1,679,400
  • Bid/Ask:
    3,984.0/3,987.0
  • Day's Range:
    3,968.0 - 4,022.0
  • Type:Equity
  • Market:Japan
  • ISIN:JP3519400000

4519 Overview

Prev. Close
4,004
Day's Range
3,968-4,022
Revenue
809.05B
Open
4,015
52 wk Range
3,898-6,435
EPS
140.15
Volume
1,679,400
Market Cap
6.58T
Dividend (Yield)
60.00
(1.50%)
Average Vol. (3m)
2,331,656
P/E Ratio
28.57
Beta
0.94
1-Year Change
-18.62%
Shares Outstanding
1,644,208,720
Next Earnings Date
Oct 22, 2021
What is your sentiment on Chugai Pharmaceutical Co., Ltd.?
or
Market is currently closed. Voting is open during market hours.

Chugai Pharmaceutical Co., Ltd. News

Chugai Pharmaceutical Co., Ltd. Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellNeutral
Technical IndicatorsSellBuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellSell

Chugai Pharmaceutical Co., Ltd. Company Profile

Chugai Pharmaceutical Co., Ltd. Company Profile

Employees
7555
Market
Japan

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.